Nyumbani › Neuroblastoma › Massachusetts
Majaribio ya kliniki ya Neuroblastoma katika jimbo la Massachusetts
Masomo 13 ya Neuroblastoma yanatafuta washiriki katika vituo vya jimbo la Massachusetts.
Miji katika jimbo la Massachusetts
Maandishi rasmi ya utafiti (Kiingereza)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
InaajiriHatua 3
Hadi umri 30 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06172296MCT for the Harvard/UCSF ROBIN Center
- Brigham and Women's Hospital, Boston
Inaajiri
Umri wote · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT06000787Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Dana-Farber Cancer Institute ( Site 1013), Boston
InaajiriHatua 1/2
6 Months – 25 Years · Jinsia zote · Imesasishwa 17 Sep 2026 · NCT06395103B7-H3.CD28Z.CART in Solid Tumors
- Dana Farber Cancer Institite, Boston
InaajiriHatua 1
9 Months – 30 Years · Jinsia zote · Imesasishwa 3 Sep 2026 · NCT07358260Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
InaajiriHatua 3
365 Days – 30 Years · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT03126916Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Dana-Farber Cancer Institute, Boston
InaajiriHatua 1/2
12 Months – 30 Years · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT04851119SPEARHEAD-3 Pediatric Study
- Dana Farber Cancer Institute, Boston
InaajiriHatua 1/2
Umri 2 hadi 21 · Jinsia zote · Imesasishwa 11 Ago 2026 · NCT05642455PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
InaajiriHatua 1/2
Umri 1 hadi 30 · Jinsia zote · Imesasishwa 22 Jul 2026 · NCT06721689NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
- Boston Children's Hospital, Dana-Farber Cancer Institute., Boston
InaajiriHatua 2
Umri 1 hadi 31 · Jinsia zote · Imesasishwa 20 Jul 2026 · NCT06450041Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
InaajiriHatua 1
Umri 1 hadi 30 · Jinsia zote · Imesasishwa 14 Jul 2026 · NCT07027748Neuroblastoma Biology Study
- Children's Hospital Boston, Boston
InaajiriUtafiti wa uchunguzi
31 Days – 99 Years · Jinsia zote · Imesasishwa 23 Mac 2026 · NCT01587300Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
- Dana-Farber Cancer Institute, Boston
Inaajiri
Hadi umri 17 · Jinsia zote · Imesasishwa 10 Feb 2026 · NCT06831552Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
InaajiriHatua 1/2
12 Months – 29 Years · Jinsia zote · Imesasishwa 26 Des 2025 · NCT06803875Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.